NCT07813195Not yet recruiting
Assessment of Erectile Dysfunction and Coronary Artery Disease Severity
Bidirectional Assessment of Erectile Dysfunction and Coronary Artery Disease Severity, Prevalence and Clinical Correlation
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
This study provides a comprehensive bidirectional assessment to determine the prevalence, clinical severity, and anatomical correlation between erectile dysfunction and coronary artery disease severity in patients presenting to cardiology and sexual health pathways.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 20 Aug 2026
- Start date
- Oct 2026
- Primary completion date
- Aug 2028
- Lead sponsor
- Assiut University
- Diseases
- Coronary artery disease
- NCT number
- NCT07813195
What you commit to
- Study type: Observational
- Planned participants: 120
- From Oct 2026 to the primary completion date, Aug 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior history of pelvic surgery, pelvic trauma, or radical prostatectomy.
Other illness
- Primary psychogenic, endocrinological (except diabetes mellitus), or neurogenic erectile dysfunction.
- Severe hepatic failure, end-stage renal disease on dialysis, or active malignancies.
- Decompensated heart failure (NYHA Class III or IV).
Other
- Patients presenting with cardiogenic shock, unstable hemodynamics.
Who the study is looking for
- 1 - Male patients aged between 18 and 50 years. 2-Patients undergoing primary or diagnostic coronary angiography due to suspected or confirmed acute, chronic coronary syndrome or stable angina.
- 3-Patients providing written informed consent to participate in the study and discuss sexual health assessments.
Age in the registry: 18 years to 50 years · Sex: Male · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.